Literature DB >> 8242776

Reduced activation of transcriptional factor AP-1 among peripheral blood T cells from elderly humans after PHA stimulation: restorative effect of phorbol diesters.

R L Whisler1, B Liu, L C Wu, M Chen.   

Abstract

In the present study, we evaluated if aging influences the activation and characteristics of transcriptional factor AP-1 in human T cells. Using gel mobility shift assays, the activation of AP-1 was quantified in peripheral blood T cells from 11 elderly (mean 74 year) and young (mean 33 year) subjects following stimulation with PHA, PMA, or PHA plus PMA. The results showed that the activation of AP-1 was significantly reduced in PHA-stimulated T cells from the group of elderly subjects when compared to T cells from young subjects (P < 0.05). Even though PHA-stimulated T cells from 8 of the elderly subjects had pronounced impairments in the activation of AP-1, additional signals provided by costimulation with PMA frequently restored AP-1 activation to more normal levels. Other experiments demonstrated that the AP-1 complexes expressed by stimulated T cells of elderly and young subjects exhibited similar properties in gel shift assays with competing unlabeled AP-1 oligonucleotides and with blocking antibodies specific for Fos and Jun. Thus, these data suggest that the activation of AP-1 can be reduced in human T cells during aging and that these reductions may often be related to impairments in signal transduction rather than represent an absolute loss in the ability to express AP-1.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8242776     DOI: 10.1006/cimm.1993.1270

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  7 in total

Review 1.  Immunosuppression in elderly renal transplant recipients: are current regimens too aggressive?

Authors:  H U Meier-Kriesche; B Kaplan
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 2.  The impact of age on rejection in kidney transplantation.

Authors:  Johan W de Fijter
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 3.  Pharmacokinetic considerations relating to tacrolimus dosing in the elderly.

Authors:  Christine E Staatz; Susan E Tett
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 4.  Immunodeficiency of aging.

Authors:  E A Burns; J S Goodwin
Journal:  Drugs Aging       Date:  1997-11       Impact factor: 4.271

5.  Myc and AP-1 expression in T cells and T-cell activation in patients after hematopoietic stem cell transplantation.

Authors:  Shivtia Trop-Steinberg; Yehudith Azar; Rachel Bringer; Reuven Or
Journal:  Clin Exp Med       Date:  2014-08-07       Impact factor: 3.984

6.  Activation and proliferation signals in primary human T lymphocytes inhibited by ergosterol peroxide isolated from Cordyceps cicadae.

Authors:  Y C Kuo; S C Weng; C J Chou; T T Chang; W J Tsai
Journal:  Br J Pharmacol       Date:  2003-09-22       Impact factor: 8.739

Review 7.  Drug therapy in transplant recipients: special considerations in the elderly with comorbid conditions.

Authors:  José F Bernardo; Jerry McCauley
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.